News

Michael Petrides elected to the Royal Society of London

Published: 13 June 2012

Congratulations to Dr. Michael Petrides, who has been elected to the prestigious Royal Society of London. Founded in 1660, the Royal Society is the independent scientific academy of the UK, dedicated to promoting excellence in science. The ceremony will be in London, UK, on July 13, 2012.
 
Dr. Petrides is a Professor of Neurology and Neurosurgery at McGill University.  Since 1990, he has been the head of The Neuro’s Cognitive Neuroscience Unit.  His special interest is the function of the frontal and parietal cortex in cognitive activity.  Dr. Petrides became a James McGill Professor in 2001 and was a Killam Scholar (2002-2007). His other accolades include:  the James S. McDonnell 21st Century Scientist Award: Bridging Brain, Mind and Behavior (2001),  election to the American Academy of Arts and Sciences in 2007 and to the Royal Society of Canada  in 2011. Dr. Petrides has demonstrated that a specific part of the dorsolateral frontal cortex tracks information in our working memory while other parts select information for retrieval from memory or select what responses to make based on acquired rules.  In the same brain regions, he has studied single cells to understand the specific activity underlying working memory and the mechanisms at work in retrieving information.  He has produced the modern architectonic maps of the frontal cortex that are used widely in the neuroscience community.

About The Neuro
The Montreal Neurological Institute and Hospital — the Neuro, is a unique academic medical centre dedicated to neuroscience. Founded in 1934 by the renowned Dr. Wilder Penfield, the Neuro is recognized internationally for integrating research, compassionate patient care and advanced training, all key to advances in science and medicine. The Neuro is a research and teaching institute of McGill University and forms the basis for the Neuroscience Mission of the McGill University Health Centre.  Neuro researchers are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders. For more information, visit theneuro.com.

 

Back to top